DRUG DISCOVERY APPROACHES FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS ALZHEIMER'S DISEASE

Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders: Alzheimer's Disease examines the drug discovery process for neurodegenerative diseases by focusing specifically on Alzheimer's Disease and illustrating the paradigm necessary to ensure future research and treatment...

Full description

Saved in:
Bibliographic Details
Other Authors: Adejare, Adeboye 1959- (Editor)
Format: Book
Language:English
Published: AMSTERDAM ELSEVIER/ACADEMIC PRESS 2017
Subjects:
Online Access:Click Here to View Status and Holdings.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000ntm a2200000#i 4501
001 wils-912269
005 201821510518
008 180315s2017 -UK a## ##001 #dENG#D
020 # # |a 9780128028100  |q hardback 
020 # # |a 0128028106  |q hardback 
040 # # |a YDX  |d UiTM  |e rda 
041 0 # |a eng 
060 0 0 |a WT 155 
090 0 0 |a WT155  |b D7943 2017 
245 0 0 |a DRUG DISCOVERY APPROACHES FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS  |b ALZHEIMER'S DISEASE  |c Edited by ADEBOYE ADEJARE 
264 # 1 |a AMSTERDAM  |b ELSEVIER/ACADEMIC PRESS  |c 2017 
264 # 4 |c ©2017 
300 # # |a xvii, 290 pages  |b illustrations  |c 24 cm 
336 # # |a text  |2 rdacontent 
337 # # |a unmediated  |2 rdamedia 
338 # # |a volume  |2 rdacarrier 
504 # # |a Includes bibliographical references and index 
520 # # |a Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders: Alzheimer's Disease examines the drug discovery process for neurodegenerative diseases by focusing specifically on Alzheimer's Disease and illustrating the paradigm necessary to ensure future research and treatment success. The book explores diagnosis, epidemiology, drug discovery strategies, current therapeutics, and much more to provide a holistic approach to the discovery, development, and treatment of Alzheimer's Disease. Through its coverage of the latest research in targeted drug design, preclinical studies, and mouse and rat models, the book is a must-have resource for all pharmaceutical scientists, pharmacologists, neuroscientists, and clinical researchers working in this area. It illustrates why these drugs tend to fail at the clinical stage, and examines Alzheimer's Disease within the overall context of improving the drug discovery process for the treatment of other neurodegenerative disorders. 
546 # # |a Text in English 
650 # 2 |a Alzheimer Disease  |x drug therapy 
650 # 2 |a Drug Discovery 
650 # 2 |a Neuroprotective Agents  |x therapeutic use 
650 # 2 |a Amyloid beta-Peptides 
700 1 # |a Adejare, Adeboye  |d 1959-  |e editor 
856 4 0 |z Click Here to View Status and Holdings.  |u https://opac.uitm.edu.my/opac/detailsPage/detailsHome.jsp?tid=912269